OPNT - Opiant Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/20177/31/20177/31/2016
Total Revenue13,982.17728,229.56118,445.9969,897.595
Cost of Revenue23,694.9169,346.8623,171.599-
Gross Profit-9,712.73918,882.69815,274.3979,897.595
Operating Expenses
Research Development---2,808.757
Selling General and Administrative11,477.70115,181.8248,022.13214,827.317
Non Recurring----
Others----
Total Operating Expenses35,172.61724,528.68611,193.73117,636.074
Operating Income or Loss-21,190.443,700.8747,252.265-7,738.479
Income from Continuing Operations
Total Other Income/Expenses Net46.40715.626-121.178-75.777
Earnings Before Interest and Taxes-21,190.443,700.8747,252.265-7,738.479
Interest Expense---4-12
Income Before Tax-21,144.0333,716.5017,131.087-7,814.256
Income Tax Expense51.283405.991550.474-
Minority Interest----
Net Income From Continuing Ops-21,195.3163,310.516,580.613-7,814.256
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,195.3163,310.516,580.613-7,814.256
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,195.3163,310.516,580.613-7,814.256